
95% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
ORIGINAL RESEARCH article
Front. Pharmacol.
Sec. Drug Metabolism and Transport
Volume 16 - 2025 | doi: 10.3389/fphar.2025.1566257
This article is part of the Research Topic New Drugs and Future Challenges in Drug Metabolism and Transport View all 19 articles
The final, formatted version of the article will be published soon.
You have multiple emails registered with Frontiers:
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Labeled nanoparticles can be monitored within the body using PET imaging, offering real-time insight into their pharmacokinetics and biodistribution. In the present work, liposomes are labeled with the radionuclide fluorine-18, exploiting the "surface radiolabeling" approach. Two alkyne-DOPE (dioleoylphosphatidylethanolamine) constructs are embedded in the bulk of the liposome bilayer composed of cholesterol and sphingomyelin, and radiolabeling is performed either via copper(I)-catalyzed cycloaddition "click" reaction (CuAAC), or cyclooctyne-driven copper-free "click" reaction (CyOctC) modality, using a suitable fluorine-18 labeled azide, obtaining good results in terms of yields, purity, stability and automation of entire radiosynthesis process. In addition, radiolabeling is also performed on liposome formulations functionalized with (i) a peptide deriving from the receptor-binding domain of apolipoprotein E (mApoE), (ii) and with a metalloproteinase (MMP)-sensitive lipopeptide (MSLP). The in vivo uptake in an orthotopic mouse model of glioma (Gli36ΔEGFR cell line) by PET/CT is performed. The results show a higher tumor/background ratio, a faster clearance rate and a lower uptake in healthy brain tissue and peripheral districts for mApoE and MSLP-functionalized liposomes, in comparison with non-functionalized ones, that prompt for further characterization. On the contrary, radiolabeled liposome uptake is higher in most peripheral organs for non-functionalized liposomes. Hence, fluorine-18 labeled liposomes can be reliably used for in vivo PET tracking of multifunctionalized nanoparticles, enabling effective investigation of their potential as drug delivery systems.
Keywords: Liposome, Radiolabeling, CuAAC, copper-free cycloaddition, PET imaging, Glioma, Metalloproteases
Received: 24 Jan 2025; Accepted: 25 Mar 2025.
Copyright: © 2025 Iannone, Kravicz, Rainone, Antoniou, Stucchi, Valtorta, Amenta, Turolla, Pellegrino, Passarella, Vino, Todde, Re, Seneci and Moresco. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Marco Iannone, Tecnomed, Fondazione dell'Università degli Studi di Milano-Bicocca, Monza, Italy
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.